tlooto
Sign up
Medicine

Correction: A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed State

Keyi Wu, Q. Ren, Yanli Wang, Yannan Zhou, Zhengzhi Liu, Yang Cheng, Qiaohuan Deng, Yingzi Cui, Haimiao Yang

2026.4.30CLINICAL DRUG INVESTIGATION

DOI: 10.1007/s40261-026-01542-2

Abstract

Abstract is not available.

Citation format

WU, Keyi, et al. Correction: A single-center, randomized, open-label, two-formulation, two-sequence, two-period crossover study to evaluate the bioequivalence of two eltrombopag olamine tablets (25 mg) in healthy chinese subjects in the fed state. CLINICAL DRUG INVESTIGATION, 2026, 46(6): 681–681.